TY - JOUR
T1 - Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World
T2 - A Review of Evidence, Policies, and Challenges
AU - Adachi, Takeya
AU - El-Hattab, Ayman W.
AU - Jain, Ritu
AU - Nogales Crespo, Katya A.
AU - Quirland Lazo, Camila I.
AU - Scarpa, Maurizio
AU - Summar, Marshall
AU - Wattanasirichaigoon, Duangrurdee
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/3
Y1 - 2023/3
N2 - This document provides a comprehensive summary of evidence on the current situation of rare diseases (RDs) globally and regionally, including conditions, practices, policies, and regulations, as well as the challenges and barriers faced by RD patients, their families, and caregivers. The document builds on a review of academic literature and policies and a process of validation and feedback by a group of seven experts from across the globe. Panelists were selected based on their academic merit, expertise, and knowledge regarding the RD environment. The document is divided into five main sections: (1) methodology and objective; (2) background and context; (3) overview of the current situation and key challenges related to RDs covering six dimensions: burden of disease, patient journey, social impact, disease management, RD-related policies, and research and development; (4) recommendations; and (5) conclusions. The recommendations are derived from the discussion undertaken by the experts on the findings of this review and provide a set of actionable solutions to the challenges and barriers to improving access to RD diagnosis and treatment around the world. The recommendations can support critical decision-making, guiding efforts by a broad range of RDs stakeholders, including governments, international organizations, manufacturers, researchers, and patient advocacy groups.
AB - This document provides a comprehensive summary of evidence on the current situation of rare diseases (RDs) globally and regionally, including conditions, practices, policies, and regulations, as well as the challenges and barriers faced by RD patients, their families, and caregivers. The document builds on a review of academic literature and policies and a process of validation and feedback by a group of seven experts from across the globe. Panelists were selected based on their academic merit, expertise, and knowledge regarding the RD environment. The document is divided into five main sections: (1) methodology and objective; (2) background and context; (3) overview of the current situation and key challenges related to RDs covering six dimensions: burden of disease, patient journey, social impact, disease management, RD-related policies, and research and development; (4) recommendations; and (5) conclusions. The recommendations are derived from the discussion undertaken by the experts on the findings of this review and provide a set of actionable solutions to the challenges and barriers to improving access to RD diagnosis and treatment around the world. The recommendations can support critical decision-making, guiding efforts by a broad range of RDs stakeholders, including governments, international organizations, manufacturers, researchers, and patient advocacy groups.
KW - burden of disease
KW - disease management
KW - health equity
KW - health policies
KW - patient journey
KW - rare diseases
KW - social impact
UR - http://www.scopus.com/inward/record.url?scp=85151660479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85151660479&partnerID=8YFLogxK
U2 - 10.3390/ijerph20064732
DO - 10.3390/ijerph20064732
M3 - Review article
AN - SCOPUS:85151660479
SN - 1661-7827
VL - 20
JO - International journal of environmental research and public health
JF - International journal of environmental research and public health
IS - 6
M1 - 4732
ER -